: Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease. The first PREM (patient-reported outcome measure)-type questionnaire that has been dedicated to assess the experience of care in COPD is the PREM-C9. : The aim of this study was to create a Polish version of the PREM-C9 and determine its psychometric characteristics.
View Article and Find Full Text PDFHealthcare (Basel)
February 2023
Background: The COVID-19 pandemic has significantly contributed to accelerating the development of telemedicine and eHealth. The main aim of this study was to assess the attitudes of patients towards remote care implemented in general practice (GP) during the pandemic.
Methods: The study was a pilot study conducted in March-April 2021, considering technical aspects of using teleconsultations, and evaluating the difficulties, advantages and disadvantages for patients.
Purpose: The purpose of this study was to immunohistochemically validate the primary tumor PSMA expression in prostate cancer (PCa) patients imaged with [Ga]Ga-PSMA PET/CT prior to surgery, with special consideration of PET-negative cases.
Methods: The study included 40 men with newly diagnosed treatment-naïve PCa imaged with [Ga]Ga-PSMA I&T PET/CT as part of the diagnostic work-up prior to radical prostatectomy. All primary tumors were routinely stained with H&E.
Background: Respiratory medicine (RM) and palliative care (PC) physicians' management of chronic breathlessness in advanced chronic obstructive pulmonary disease (COPD), fibrotic interstitial lung disease (fILD) and lung cancer (LC), and the influence of practice guidelines was explored via an online survey.
Methods: A voluntary, online survey was distributed to RM and PC physicians via society newsletter mailing lists.
Results: 450 evaluable questionnaires (348 (77%) RM and 102 (23%) PC) were analysed.
Eur J Nucl Med Mol Imaging
January 2020
Purpose: The present study is based on a retrospective analysis of Gallium-68 (Ga)-labelled prostate-specific membrane antigen (Ga-PSMA I&T) PET/CT performed in newly diagnosed, treatment-naïve prostate cancer (PCa) patients prior to definitive treatment.
Methods: A total of 82 men were included in the study and were imaged with Ga-PSMA I&T PET/CT to assess the distribution of PSMA-avid disease for staging purposes (11 with low-risk, 32 with intermediate-risk, and 39 with high-risk PCa). Forty patients (20 with intermediate- and 20 with high-risk disease) underwent subsequent radical prostatectomy with extended pelvic lymph node dissection which allowed for correlation of imaging findings with histopathologic data.